Standout Papers

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis 2015 2026 2018 2022 1.5k
  1. Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis (2015)
    Matthew J. Armstrong, Diana Hull et al. Journal of Hepatology
  2. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study (2015)
    Matthew J. Armstrong, Piers Gaunt et al. The Lancet

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 63 standout
Sub-graph 1 of 20

Citing Papers

Adipose tissue retains an epigenetic memory of obesity after weight loss
2024 StandoutNature
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
1 intermediate paper

Works of Darren Barton being referenced

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout

Author Peers

Author Last Decade Papers Cites
Darren Barton 1609 634 596 1285 26 2.2k
Mark Aldersley 1417 546 573 1018 25 1.9k
Piers Gaunt 1288 351 368 1034 21 1.7k
Jonathan Hazlehurst 2055 608 536 1710 42 3.0k
Leyla de Avila 1924 368 826 962 35 2.3k
Julia C. Iezzoni 1837 567 933 767 43 2.7k
David Ka‐Wai Yeung 2021 370 720 907 21 2.6k
George A. Bannayan 1196 387 323 779 27 2.0k
Stefan Stender 1595 540 497 898 47 2.5k
Hironori Mawatari 1964 436 974 743 51 2.4k
Kittichai Promrat 2314 329 1137 1123 34 2.7k

All Works

Loading papers...

Rankless by CCL
2026